HIGHLIGHTS
- who: Kei Yamamoto and colleagues from the Japan, Sanyo Chemical Industries, Ltd, Higashiyama-ku, Kyoto, Japan Editor:, Stanford University have published the article: Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-u03bb3, CCL17, and calprotectin considering the timing of clinical need for prediction, in the Journal: PLOS ONE of 24/03/2022
- what: Although the predictive ability of Yamada et_al in the present two scores was not high, the results of this study were reasonable because the cutoff was determined to increase sensitivity. The authors used conserved serum to predict . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.